The use of therapeutic vaccines presents a new way to manage diseases, such as cancer and sexually transmitted diseases.
As research into harnessing the immune system's natural ability to fight disease advances, so does the development of therapeutic vaccines. Much of the attention in therapeutic vaccine R&D is aimed at targeted therapies for cancer, but substantial research is also going into therapeutic vaccines for other indications, including sexually transmitted diseases.
Download
Pharmaceutical Technology and BioPharm International’s 2017 Vaccine Development and Manufacturing 2017eBook.
Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 20–24
When referring to this article, please cite it as F. Mirasol, "Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Pfizer Obtains Exclusive Rights to 3SBio’s Bispecific Antibody Targeting PD-1 and VEGF
July 25th 2025The licensing agreement between the two companies gives Pfizer the rights to develop, manufacture, and commercialize 3SBio’s bispecific antibody, SSGJ-707, which is in clinical trials for the treatment of a variety of cancers.
Pfizer Obtains Exclusive Rights to 3SBio’s Bispecific Antibody Targeting PD-1 and VEGF
July 25th 2025The licensing agreement between the two companies gives Pfizer the rights to develop, manufacture, and commercialize 3SBio’s bispecific antibody, SSGJ-707, which is in clinical trials for the treatment of a variety of cancers.
2 Commerce Drive
Cranbury, NJ 08512